2025年4月18日 周五
Home > Archive>Volume 27, Issue 4, 2019 >364-368
PDF HTML XML Export Cite reminder
Research progress on statins resistance and its molecular mechanisms
CSTR:
[cstr]
Author:
Affiliation:

Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China)

Clc Number:

R543

  • Article
    • | |
  • Metrics
    • |
  • Reference
    • |
  • Related
    • |
  • Cited by
    • | |
  • Comments
    Abstract:

    Dyslipidemia is a major risk factor for cardiovascular disease, especially elevated low density lipoprotein cholesterol (LDLC) significantly increases the incidence of atherosclerotic cardiovascular disease (ASCVD). Statins have shown to be effective in reducing serum LDLC, thereby reducing the risk of ASCVD. However, in the course of clinical application of statins, more and more studies show that statins have drug resistance. Studies have shown that statin resistance is mainly affected by drug absorption, transport, metabolism and drug action itself. Intensive study of statin resistance can provide theoretical basis for further revealing the action mechanism of statins, and hopefully provide a target for the development of new lipid-lowering drugs.

    Reference
    Related
    Cited by
Get Citation

LI Yang, MAIMAITI Ailifeire, WANG Yongtao, FU Zhenyan, MA Yitong. Research progress on statins resistance and its molecular mechanisms[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2019,27(4):364-368.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 04,2018
  • Revised:June 19,2018
  • Online: April 08,2019
Article QR Code

You are the 32720 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025